This suggests that ectopic overexpression of TMEM16A may cause hyperinsulinemia, accompanied by a transition from simple hyperlipidemia to insulin resistance and, subsequently, NAFLD. This evidence concerns the gene ANO1 and metabolic dysfunction-associated steatotic liver disease.